COSMOS Pharmaceutical Corporation (3349.T)
JPY 6521.0
(-1.63%)
JPY 6521.0
(-1.63%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 964.98 Billion | 827.69 Billion | 755.41 Billion | 726.42 Billion | 684.4 Billion | 611.13 Billion |
| Cost of Revenue | 794.95 Billion | 658.97 Billion | 603.96 Billion | 581.31 Billion | 549.41 Billion | 489.35 Billion |
| Gross Profit | 170.03 Billion | 168.71 Billion | 151.44 Billion | 145.11 Billion | 134.98 Billion | 121.78 Billion |
| Operating Expenses | 156.8 Billion | 138.58 Billion | 121.65 Billion | 111.96 Billion | 105.89 Billion | 97 Billion |
| Selling, General and Administrative Expenses | 138.53 Billion | 122.8 Billion | 107.75 Billion | 99.16 Billion | 93.34 Billion | 85.05 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 18.26 Billion | 2.96 Billion | 3.06 Billion | 2.74 Billion | 2.54 Billion | 2.52 Billion |
| Cost and Expenses | 933.48 Billion | 797.56 Billion | 725.61 Billion | 693.27 Billion | 655.3 Billion | 586.36 Billion |
| Operating Income | 31.5 Billion | 30.12 Billion | 29.79 Billion | 33.14 Billion | 29.09 Billion | 24.77 Billion |
| Interest Expense | 99 Million | 51 Million | 52 Million | 60 Million | 69 Million | 77 Million |
| Income Tax Expense | 9.26 Billion | 8.97 Billion | 9.89 Billion | 11.43 Billion | 8.96 Billion | 7.95 Billion |
| Earnings before Tax | 33.71 Billion | 32.77 Billion | 33.04 Billion | 38.59 Billion | 30.4 Billion | 27.13 Billion |
| Net Income | 24.45 Billion | 23.79 Billion | 23.15 Billion | 27.15 Billion | 21.43 Billion | 19.18 Billion |
| Earnings Per Share Basic | 308.61 | 300.48 | 292.37 | 342.89 | 270.65 | 242.24 |
| Earnings Per Share Diluted | 308.61 | 300.48 | 292.37 | 342.89 | 270.65 | 242.24 |
| Weighted Average Shares Outstanding | 79.23 Million | 79.19 Million | 79.19 Million | 79.19 Million | 79.19 Million | 79.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 79.23 Million | 79.19 Million | 79.19 Million | 79.19 Million | 79.19 Million | 79.19 Million |
| Gross Margin | 0.18 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| EBIT Margin | 0.05 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 |
| Profit Margin | 0.03 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 |
| EBITDA | 51.42 Billion | 47.49 Billion | 44.9 Billion | 46.93 Billion | 42.65 Billion | 37.73 Billion |
| Earnings Before Tax Margin | 0.03 | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 261.84 Billion | 249.67 Billion | 964.98 Billion | 238.88 Billion | 234.77 Billion | 241.65 Billion |
| Cost of Revenue | 207.27 Billion | 201.03 Billion | 794.95 Billion | 192.14 Billion | 188.85 Billion | 194.64 Billion |
| Gross Profit | 54.56 Billion | 48.64 Billion | 170.03 Billion | 46.73 Billion | 45.91 Billion | 47.01 Billion |
| Operating Expenses | 42.98 Billion | 40.87 Billion | 138.53 Billion | 38.83 Billion | 39.07 Billion | 38.02 Billion |
| Selling, General and Administrative Expenses | 42.98 Billion | 40.87 Billion | - | 38.83 Billion | 39.07 Billion | 38.02 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 659 Million | 2.85 Billion | 672 Million | 807 Million | 715 Million |
| Cost and Expenses | 250.26 Billion | 241.91 Billion | 933.48 Billion | 230.98 Billion | 227.93 Billion | 232.66 Billion |
| Operating Income | 11.58 Billion | 7.76 Billion | 31.5 Billion | 7.9 Billion | 6.84 Billion | 8.99 Billion |
| Interest Expense | 49 Million | 46 Million | 99 Million | 18 Million | 17 Million | 18 Million |
| Income Tax Expense | 3.92 Billion | 681 Million | 9.26 Billion | 2.95 Billion | 2.49 Billion | 3.12 Billion |
| Earnings before Tax | 12.06 Billion | 7.77 Billion | 33.71 Billion | 8.72 Billion | 7.57 Billion | 9.63 Billion |
| Net Income | 8.14 Billion | 7.09 Billion | 24.45 Billion | 5.77 Billion | 5.07 Billion | 6.5 Billion |
| Earnings Per Share Basic | 102.74 | 89.54 | - | 72.80 | 64.09 | 82.17 |
| Earnings Per Share Diluted | 102.74 | 89.54 | - | 72.80 | 64.09 | 82.17 |
| Weighted Average Shares Outstanding | 79.25 Million | 79.25 Million | 79.23 Million | 79.25 Million | 79.24 Million | 79.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 79.25 Million | 79.25 Million | 79.23 Million | 79.25 Million | 79.24 Million | 79.19 Million |
| Gross Margin | 0.21 | 0.19 | 0.18 | 0.20 | 0.20 | 0.19 |
| EBIT Margin | 0.07 | 0.05 | - | 0.05 | 0.03 | 0.04 |
| Profit Margin | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 |
| EBITDA | 17.3 Billion | 13.18 Billion | - | 12.99 Billion | 7.66 Billion | 9.71 Billion |
| Earnings Before Tax Margin | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
CASE
7044
PANCARBON
600731
RIDDHICORP
SGD